TrialEuropean journal of drug metabolism and pharmacokinetics2016

The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties.

Kiyohiko Nakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.